UMIN ID: UMIN000002329
Registered date:18/08/2009
Study on preoperative concurrent chemoradiotherapy with S-1 in oral cancer (Phase II study)
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Oral cancer |
| Date of first enrollment | 2009/08/01 |
| Target sample size | 15 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | The total 40Gy of irradiation is delivered to both primary site and metastasized neck region. Chemotherapy regimen consisted of 5-day S-1 consecutive administration, followed by 2-day rest for 4 weeks. |
Outcome(s)
| Primary Outcome | Tumor reduction 4 weeks after chemoradiotherapy |
|---|---|
| Secondary Outcome | Adverse events on chemoradiotherapy |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | The cases who have simultaneously another cancer, the cases who have severe complication in their body |
Related Information
| Primary Sponsor | Oral and Maxillofacial Surgery, Graduate School, Tokyo Medical and Dental University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | none |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hideki Nakayama |
| Address | 1-1-1, Honjyo, Chuo-ku, Kumamoto Japan |
| Telephone | 096-373-5288 |
| hinakaya@fc.kuh.kumamoto-u.ac.jp | |
| Affiliation | Graduate School, Kumamoto university Oral & Maxillofacial Surgery |
| scientific contact | |
| Name | Ken Omura |
| Address | 1-5-45, Yushima, Bunkyo-ku, Tokyo Japan |
| Telephone | 03-5803-5506 |
| omura.osur@tmd.ac.jp | |
| Affiliation | Graduate School, Tokyo Medical and Dental University Oral and Maxillofacial Surgery |